References
- Bhalla Jaya Shroff (2015). “PNDT Act a Failure, Legalise Ultrasound Tests: Maneka.” Pioneer (New Delhi) 5 April (http://www.dailypioneer.com/sunday-edition/sunday-pioneer/landmark/pndt-act-a-failure-legalise-ultrasound-tests-maneka.html).
- Bharadwaj Aditya (2012). “Enculturating Cells: The Anthropology, Substance, and Science of Stem Cells.” Annual Review of Anthropology 41: 303–17.
- Bharadwaj Aditya (2014). “Experimental Subjectification: The Pursuit of Human Embryonic Stem Cells in India.” Ethnos 79, no. 1: 84–107.
- Bharadwaj Aditya , and Glasner Peter (2009). Local Cells, Global Science: The Rise of Embryonic Stem Cell Research in India. London: Routledge.
- CDSCO (Central Drugs Standard Control Organization) (2013). Guidance Document for Regulatory Approvals of Stem Cell and Cell Based Products (SCCPs). SCCPs/SPS/2013-001, version 004, 30 December. New Delhi: CDSCO.
- Chen Lin , Guo Jianfeng , Sharma Alok , Sharma Aruna , Sharma Hari , Kaper Stephen D. , and Huang Hongyun (2014). “Summary Report of the International Association of Neurorestoratology VII Conference.” CNS and Neurological Disorders—Drug Targets 13, no. 6: 921.
- Cohen Cynthia B. , and Cohen Peter J. (2010). “International Stem Cell Tourism and the Need for Effective Regulation: Part 1: Stem Cell Tourism in Russia and India: Clinical Research, Innovative Treatment, or Unproven Hype?” Kennedy Institute of Ethics Journal 20, no. 1: 27–49.
- Dhar A. (2010). “Medical Ethics Violation to Be Made Punishable Offence.” Hindu 1 August (http://www.thehindu.com/news/national/medical-ethics-violation-to-be-made-punishable-offence/article544767.ece).
- Garg Sunila , and Nath Anita (2008). “Female Feticide in India: Issues and Concerns.” Journal of Postgraduate Medicine 54: 276–79.
- Gupta S. K. , and Gandhi Brij Mohan (2014). “Unregulated Stem Cell Therapy—a Frankenstein Monster in the Absence of Effective Laws.” Financial Express 18 February (http://pharma.financialexpress.com/sections/management/3409-unregulated-stem-cell-therapy-a-frankenstein-monster-in-the-absence-of-effective-laws).
- ICMR-DBT (Indian Council of Medical Research, Department of Biotechnology) (2007). Guidelines for Stem Cell Research and Therapy. New Delhi: ICMR-DBT.
- ICMR-DBT (Indian Council of Medical Research, Department of Biotechnology) (2013). National Guidelines for Stem Cell Research. New Delhi: ICMR-DBT.
- Inamdar Maneesha S. , Venu Parvathy , Srinivas M. S. , Rao Kamini , and VijayRaghavan K. (2009). “Derivation and Characterization of Two Sibling Human Embryonic Stem Cell Lines from Discarded Grade III Embryos.” Stem Cells and Development 18, no. 3: 423–34.
- Jain Kalpana (2010). “Doctors Question Impact of Code of Conduct without Punishment.” Business Standard 2 January (http://www.business-standard.com/article/economy-policy/doctors-questionimpact-of-code-of-conduct-without-punishment-110010200009_1.html).
- Jayaraman K. S. (2005). “Indian Regulations Fail to Monitor Growing Stem-Cell Use in Clinics.” Nature 434: 259.
- Kahn Jennifer (2006). “A Nation of Guinea Pigs: How India Became the Global Hot Spot for Clinical Trials.” Wired Magazine 14, no. 3 ( http://www.wired.com/wird/archive/14.03/indiadrug.html ).
- Kiatpongsan Sorapop , and Sipp Douglas (2008). “Offshore Stem Cell Treatments.” Nature Reports Stem Cells 3 December (http://www.nature.com/stemcells/2008/0812/081203/full/stemcells.2008.151.html).
- Lander Bryn , Thorsteinsdottir Halla , Singer Peter A. , and Daar Abdallah S. (2008). “Harnessing Stem Cells for Health Needs in India.” Cell Stem Cell 3, no. 1: 11–15.
- O'Kelly Morton E. (1998). “A Geographer's Analysis of Hub-and-Spoke Networks.” Journal of Transport Geography 6, no. 3: 171–86.
- Pandya Sunil (2008). “Stem Cell Transplantation in India: Tall Claims, Questionable Ethics.” Indian Journal of Medical Ethics 5, no. 1: 15–17.
- Patra Prasanna Kumar , and Sleeboom-Faulkner Margaret (2009). “Bionetworking: Experimental Stem Cell Therapy and Patient Recruitment in India.” Anthropology and Medicine 16, no. 2: 147–63.
- Patra Prasanna Kumar , and Sleeboom-Faulkner Margaret (2010). “Bionetworking: Between Guidelines and Practice in Stem Cell Therapy Enterprise in India.” SCRIPTed—a Journal of Law, Technology, and Society 7, no. 2: 295–310.
- Patra Prasanna Kumar , and Sleeboom-Faulkner Margaret (2011). “Recruiter-Patients as Ambiguous Symbols of Health—Bionetworking and Stem Cell Therapy in India.” New Genetics and Society 30, no. 2: 155–66.
- Patra Prasanna Kumar , and Sleeboom-Faulkner Margaret (2013). “Discursive Dialects of Bioethics: Understanding the Institutional Embeddings of Human Stem Cell Experimentation in India.” BioSocieties 8, no. 1: 75–92.
- Porter Michael E. (2000). “Location, Competition, and Economic Development: Local Clusters in a Global Economy.” Economic Development Quarterly 14, no. 1: 15–34.
- Salter Brian (2008). “Governing Stem Cell Science in China and India: Emerging Economies and the Global Politics of Innovation.” New Genetics and Society 27, no. 2: 145–59.
- Sharma Alka (2009). “Stem Cell Research and Policy in India: Current Scenario and Future Perspective.” Journal of Stem Cells 4, no. 2: 133–40.
- Singh Abhimanyu (2011). “Panel to Discuss AIIMS Stem Cells Trials.” Sunday Guardian, 26 June (http://www.sunday-guardian.com/news/panel-to-discuss-aiims-stem-cell-trials).
- Sleeboom-Faulkner Margaret (2010). “Contested Embryonic Culture in Japan—Public Discussion, and Human Embryonic Stem Cell Research in an Aging Welfare Society.” Medical Anthropology 29, no. 1: 44–70.
- Sleeboom-Faulkner Margaret (2011). “Looking beyond the Regulatory Exteriors of Stem Cell Research in Asia—Discussion.” New Genetics and Society 30, no. 3: 279–88.
- Sleeboom-Faulkner Margaret (2014). “Experimentation: Why Beike Biotech Is ‘Acceptable.’” Presentation at the fifth biannual “Bionetworking in Asia” meeting, 13–16 January, Brighton, UK.
- Sleeboom-Faulkner Margaret (2016). “The Large Grey Area between ‘Bona Fide’ and ‘Rogue’ Stem Cell Interventions—Ethical Acceptability and the Need to Include Local Variability.” Technological Forecasting and Social Change 109: 76–86.
- Sleeboom-Faulkner Margaret , and Hwang Seyoung (2012). “Governance of Stem Cell Research: Public Participation and Decision-Making in China, Japan, South Korea, Taiwan and the UK.” Social Studies of Science 42, no. 5: 684–708.
- Sleeboom-Faulkner Margaret , and Patra Prasanna Kumar (2008). “The Bioethical Vacuum: National Policies on Human Embryonic Stem Cell Research in India and China.” Journal of International Biotechnology Law 5, no. 6: 221–34.
- Sleeboom-Faulkner Margaret , and Patra Prasanna Kumar (2011). “Experimental Stem Cell Therapy: Biohierarchies and Bionetworking in Japan and India.” Social Studies of Science 41, no. 5: 645–66.
- Srinivasan Sandhya (2006). Rogue Research in the Guise of Stem Cell Therapy, Infochange Public Health (http://www.infochangeindia.org/index.php?option = com_content&view = article&id = 278:rogue-research-in-the-guise-of-stem-celltherapy&catid = 111:features&Itemid = 30, accessed 24 August 2014).
- Sunder Rajan Kaushik (2007). “Experimental Values: Indian Clinical Trials and Surplus Health.” New Left Review 45: 67–88.
- Tiwari Shashank Sekhar , and Desai Pranav N. (2011). “Stem Cell Innovation System in India: Emerging Scenario and Future Challenges.” World Journal of Science Technology and Sustainable Development 8, no. 1: 1–23.
- Tiwari Shashank Sekhar , and Raman Sujatha (2014). “Governing Stem Cell Therapy in India: Regulatory Vacuum or Jurisdictional Ambiguity?” New Genetics and Society 33, no. 4: 413–33.
- Turner Leigh (2007). “‘First World Healthcare at Third World Prices’: Globalization, Bioethics and Medical Tourism.” BioSocieties 3, no. 2: 303–25.
- Waldby Catherine , and Mitchell Robert (2007). Tissue Economies—Blood, Organs, and Cell Lines in Late Capitalism. Durham, NC: Duke University Press.
- World Medical Association (2008). Declaration of Helsinki: Ethical Principles for Medical Research Involving Human Subjects (https://www.wma.net/policies-post/wma-declaration-of-helsinki-ethical-principles-for-medical-research-involving-human-subjects/, accessed 14 January 2014).